Increased healthcare spending and emphasis on chronic disease management are fueling the use of GLP-1 therapy
These resources include: A CISP Checklist Implementing Revised List (available now) Athlete and ASP Guide to the 2025 List (to be available mid-December) Languages and formats The 2025 Prohibited List, the 2025 Summary of Modifications and Explanatory Notes, and the 2025 Monitoring Program are available for download on WADAs website in English and French, with Spanish to follow in the coming weeks
After 5 weeks of treatment with once-daily subcutaneous administration of liraglutide 1.8 mg and 3.0 mg, estimated reductions in body weight were 2.1 kg and 2.5 kg, respectively, vs
The most striking symptom is its most life-threatening: an insatiable hunger known as hyperphagia that prompts caregivers to padlock cupboards and fridges, chain garbage cans, and install cameras
Week 3-4 (First dose increase): Nausea may intensify temporarily